HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 288/6/R1774    most recent 00815.2004v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Sapirstein, A. Articles by Bonventre, J. V. Search for Related Content PubMed PubMed Citation Articles by Sapirstein, A. Articles by Bonventre, J. V.

INFLAMMATION AND CYTOKINES

Cytosolic phospholipase A₂ regulates induction of brain cyclooxygenase-2 in a mouse model of inflammation

¹Anesthesiology and Critical Care Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland; ²Department of Pharmacy, Kumamoto University Hospital, Kumamoto, Japan; ³Neural Plasticity Research Group, Department of Anesthesia, Massachusetts General Hospital, Boston; ⁴Medical Services, Brigham and Women’s Hospital, Boston; and ⁵Harvard-MIT Division of Health Sciences and Technology, Boston, Massachusetts

Submitted 1 December 2004 ; accepted in final form 4 February 2005

The products of arachidonic acid metabolism are key mediators of inflammatory responses in the central nervous system, and yet we do not know the mechanisms of their regulation. The phospholipase A₂ enzymes are sources of cellular arachidonic acid, and the enzymes cyclooxygenase-2 (COX-2) and microsomal PGE synthase-1 (mPGES-1) are essential for the synthesis of inflammatory PGE₂ in the brain. These studies seek to determine the function of cytosolic phospholipase A₂ (cPLA₂) in inflammatory PGE₂ production in the brain. We wondered whether cPLA₂ functions in inflammation to produce arachidonic acid or to modulate levels of COX-2 or mPGES-1. We investigated these questions in the brains of wild-type mice and mice deficient in cPLA₂ (cPLA₂^–/–) after systemic administration of LPS. cPLA₂^–/– mice had significantly less brain COX-2 mRNA and protein expression in response to LPS than wild-type mice. The reduction in COX-2 was most apparent in the cells of the cerebral blood vessels and the leptomeninges. The brain PGE₂ concentration of untreated cPLA₂^–/– mice was equal to their wild-type littermates. After LPS treatment, however, the brain concentration of PGE₂ was significantly less in cPLA₂^–/– than in cPLA₂^+/+ mice (24.4 ± 3.8 vs. 49.3 ± 11.6 ng/g). In contrast to COX-2, mPGES-1 RNA levels increased equally in both mouse genotypes, and mPGES-1 protein was unaltered 6 h after LPS. We conclude that cPLA₂ regulates COX-2 levels and modulates inflammatory PGE₂ levels. These results indicate that cPLA₂ inhibition is a novel anti-inflammatory strategy that modulates, but does not completely prevent, eicosanoid responses.

lipopolysaccharide; prostaglandin E synthase; inflammation; prostaglandin E₂

This article has been cited by other articles:

				L. Xu, C. Han, and T. Wu A Novel Positive Feedback Loop between Peroxisome Proliferator-activated Receptor-{delta} and Prostaglandin E2 Signaling Pathways for Human Cholangiocarcinoma Cell Growth J. Biol. Chem., November 10, 2006; 281(45): 33982 - 33996. [Abstract] [Full Text] [PDF]